Pandey, Pankaj https://orcid.org/0000-0001-9128-8254
Zagzoog, Ayat Hesham
Zaharia, Theodor
Chatterjee, Shamba
Khan, Ikhlas A.
Paris, Jason J.
Laprairie, Robert B. https://orcid.org/0000-0002-9994-433X
Chittiboyina, Amar G. https://orcid.org/0000-0002-7047-5373
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P30GM122733-01A1)
U.S. Department of Health & Human Services | NIH | National Center for Research Resources (C06RR14503)
Article History
Received: 20 September 2025
Accepted: 12 March 2026
First Online: 28 March 2026
Competing interests
: The authors declare the following competing financial interest(s): R.B.L. has received compensation on legal cases involving Cannabis, has served as a consultant on the scientific advisory board for Shackleford Pharma Inc., and is pursuing patents on compounds unrelated to the contents of this study. P.P., A.Z., R.B.L., R.J.D., I.A.K. and A.G.C have filed a patent application for compounds related to, and including CBDP described in this manuscript. This disclosure is provided for transparency regarding their ongoing work. All other authors declare no competing interests.